Hegg, R., Mattar, A., Matos-Neto, J. N. de, Pedrini, J. L., Aleixo, S. B., Rocha, R. O., Cramer-Junior, R. P., & van-Eyll-Rocha, S. (2016). A phase III, randomized, non-inferiority study comparing the efficacy and safety of biosimilar filgrastim versus originator filgrastim for chemotherapy-induced neutropenia in breast cancer patients . Clinics, 71(10), 586-592. https://doi.org/10.6061/clinics/2016(10)06